Melatonin for the management of sleep problems in children with neurodevelopmental disorders: a systematic review and meta-analysis

@article{Abdelgadir2018MelatoninFT,
  title={Melatonin for the management of sleep problems in children with neurodevelopmental disorders: a systematic review and meta-analysis},
  author={Ibtihal Siddiq Abdelgadir and Morris Gordon and Anthony K Akobeng},
  journal={Archives of Disease in Childhood},
  year={2018},
  volume={103},
  pages={1155 - 1162}
}
Importance Children with neurodevelopmental disorders have a higher prevalence of sleep disturbances. Currently there is variation in the use of melatonin; hence, an up-to-date systematic review is indicated to summarise the current available evidence. Objective To determine the efficacy and safety of melatonin as therapy for sleep problems in children with neurodevelopmental disorders. Data sources and study selections PubMed, Embase, the Cumulative Index to Nursing and Allied Health… Expand
Efficacy and safety of melatonin for sleep onset insomnia in children and adolescents: a meta-analysis of randomized controlled trials.
TLDR
Melatonin was an effective and tolerable drug in the short-term treatment of sleep onset insomnia in children and adolescents and more studies are needed to investigate the efficacy and safety of melatonin. Expand
Adverse Events Associated with Melatonin for the Treatment of Primary or Secondary Sleep Disorders: A Systematic Review
TLDR
There are insufficient robust data to allow a meaningful appraisal of concerns that melatonin may result in more clinically significant adverse effects in potentially at-risk populations, and the scarcity of evidence from long-term RCTs limits the conclusions regarding the safety of continuous melatonin therapy over extended periods. Expand
Long-term melatonin treatment for the sleep problems and aberrant behaviors of children with neurodevelopmental disorders
TLDR
Long-term melatonin treatment in combination with adequate sleep hygiene interventions may afford clinical benefits to children with NDDs and potentially elevates their well-being. Expand
The use and misuse of exogenous melatonin in the treatment of sleep disorders
  • R. Riha
  • Medicine
  • Current opinion in pulmonary medicine
  • 2018
TLDR
There is evidence for the efficacy of melatonin in the management of insomnia and some intrinsic disorders of circadian rhythm in adults and children as well as in reducing sleep onset latency in jet-lag and shift work disorder in adults. Expand
Pediatric sleep disturbances and treatment with melatonin
TLDR
Melatonin can be safe and effective in treating both primary sleep disorders and the sleep disorders associated with various neurological conditions, however, there is a need for further studies aimed at identifying the sleep disordered infants and children who will benefit most from melatonin treatment, and determining appropriate doses based on the severity and type of disorder. Expand
Melatonin use for sleep disturbance in children with cerebral palsy: a narrative review
TLDR
Due to the variance in the product, minimal number of studies, adverse effect potential, and lack of data on doses in children, melatonin should be used with caution in children with cerebral palsy. Expand
Pharmacotherapeutic management of sleep disorders in children with neurodevelopmental disorders
TLDR
This narrative review, the authors highlight and summarize the most common drugs and supplements used for the treatment of sleep problems in children with neurodevelopmental disabilities and recommend the use of melatonin and melatonin receptor agonists, sedating antidepressants, antipsychotics, antihistamines, gabapentin, clonidine and orexin receptor antagonists, and benzodiazepines and hypnotic Benzodiazepine receptor agonist. Expand
Melatonin Treatment and Adequate Sleep Hygiene Interventions in Children with Autism Spectrum Disorder: A Randomized Controlled Trial.
TLDR
This therapeutic regimen of melatonin is a reasonable clinical approach to cope with ASD-emergent difficulties in children with ASD. Expand
Efficacy and safety of supplemental melatonin for delayed sleep–wake phase disorder in children: an overview
TLDR
Evidence has been provided that melatonin is an efficacious and safe chronobiotic drug for the treatment of DSPD in children, provided that it is administered at the correct time (3–5 h before endogenous melatonin starts to rise in dim light (DLMO)), and in the correct (minimal effective) dose. Expand
Behavioural Treatments for Sleep Problems in Children with Autism Spectrum Disorder: a Review of the Recent Literature
TLDR
Clinically, behavioural sleep interventions are regarded as the first-line of treatment for sleep problems experienced by children with ASD, however, there is still much to be learnt regarding their clinical effectiveness. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 37 REFERENCES
Systematic review of melatonin treatment in children with neurodevelopmental disabilities and sleep impairment.
TLDR
Despite the extremely limited randomized clinical trial data, melatonin appears to remain a commonly prescribed drug for disturbed sleep in children with neurodevelopmental abnormalities. Expand
The use of MElatonin in children with neurodevelopmental disorders and impaired sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS).
TLDR
Melatonin is effective in reducing SOL in children with neurodevelopmental delay by a mean of 45 minutes; a value of 30 minutes was specified a priori to be clinically important and will be published in full in Health Technology Assessment. Expand
Melatonin for Treatment of Sleep Disorders in Children With Developmental Disabilities
TLDR
The greater the sleep latency was at baseline or when receiving placebo, the more pronounced was the decrease in sleep latency with melatonin, suggesting that synthetic melatonin reduces sleep latency in children with developmental disabilities. Expand
Exogenous melatonin for sleep problems in individuals with intellectual disability: a meta‐analysis
TLDR
A meta‐analysis of placebo‐controlled randomized trials of melatonin in individuals with intellectual disabilities and sleep problems showed that melatonin treatment decreased sleep latency, increased total sleep time, and significantly decreased the number of wakes per night. Expand
Pharmacological treatment of sleep disturbance in developmental disabilities: a review of the literature.
TLDR
Melatonin appears to be the most widely assessed agent and safest choice for children with developmental disabilities and Trazodone, mirtazapine, and ramelteon hold promise but require further study. Expand
Melatonin Treatment for Insomnia in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder
TLDR
It is suggested that melatonin is a well-tolerated and efficacious treatment option for pediatric patients with chronic SOI and ADHD and Regulated melatonin products and larger, well-designed trials to establish optimal dosing regimens and long-term safety are needed. Expand
Current role of melatonin in pediatric neurology: clinical recommendations.
TLDR
Animal work and limited human data suggest that melatonin does not exacerbate seizures and might decrease them, and animal work has confirmed a neuroprotective effect of melatonin, suggesting a role in minimising neuronal damage from birth asphyxia. Expand
Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia.
TLDR
Combined sleep hygiene and melatonin was a safe and effective treatment for initial insomnia in children with ADHD taking stimulant medication. Expand
Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia.
TLDR
Melatonin advanced circadian rhythms of sleep-wake and endogenous melatonin and enhanced total time asleep in children with ADHD and chronic sleep onset insomnia; however, no effect was found on problem behavior, cognitive performance, or quality of life. Expand
Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder.
TLDR
PedPRM was efficacious and safe for treatment of insomnia in children and adolescents with ASD with/without ADHD and NGD, and the acceptability of this pediatric formulation in a population who usually experience significant difficulties in swallowing was remarkably high. Expand
...
1
2
3
4
...